InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Canepa John J, Chief Financial Officer. Director active across 1 companies, notably Candel Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €136k. The latest transaction was filed on 29 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€68,10710,125 shares@ €6.7266100.0% of flow
Common Stock
SEC:0000899243-21-031092·
Ideal exit: 25 Apr 2022 (T+270)
€68,10710,125 shares@ €6.72660.022% mcap50.0% of flow
Common Stock
SEC:0000899243-21-031092:0·
Ideal exit: 25 Apr 2022 (T+270)
2 of 2 declarations
About Canepa John J
John J. Canepa is the Chief Financial Officer at Candel Therapeutics, Inc. He oversees the financial management of the company, including planning and financial reporting. His expertise is crucial for the financial health of the business.
